AGREEMENT AND PLAN OF MERGER
This AGREEMENT AND PLAN OF MERGER (the “Agreement”) is entered into as of 4:02 p.m. Eastern Time on November 7, 2023, by and among Amneal Pharmaceuticals, Inc. (f/k/a Amneal NewCo Inc.), a Delaware corporation (“New PubCo”), Amneal Pharmaceuticals LLC, a Delaware limited liability company and an indirect subsidiary of New PubCo (“OpCo”) and Amneal Merger Sub 2 LLC, a Delaware limited liability company and a direct, wholly-owned subsidiary of New PubCo (“Merger Sub 2”) (each a “Party” and collectively the “Parties”).
W I T N E S S E T H
WHEREAS, Section 18-209 of the Delaware Limited Liability Company Act, 6 Del. C. § 18-101, et seq., as amended (the “DLLCA”), authorizes the merger of one or more Delaware limited liability companies with and into a Delaware limited liability company;
WHEREAS, Merger Sub 2 desires to merge with and into OpCo (the “Merger”), following which OpCo shall be the surviving entity;
WHEREAS, New PubCo, as the sole and managing member of Merger Sub 2, is executing this Agreement to approve the consummation of the Merger;
WHEREAS, Amneal Intermediate, Inc. (f/k/a/ Amneal Pharmaceuticals, Inc.), a Delaware corporation (“Old PubCo”), as managing member of OpCo, is executing this Agreement to approve the consummation of the Merger and the Agreement has also been approved by the Conflicts Committee (as defined in the OpCo LLCA (as defined below)) and by the members of OpCo by written consent as provided in and pursuant to Section 7.05 of the Third Amended and Restated Limited Liability Company Agreement of OpCo (the “OpCo LLCA”);
WHEREAS, as of the Effective Time (as defined below), OpCo will have the authority to issue limited liability company interests, represented by common units (the “OpCo Common Units”), of which 152,116,890 units are issued and outstanding (excluding any OpCo Common Units owned by Old PubCo);
WHEREAS, as of the date hereof, Merger Sub 2 has the authority to issue limited liability company interests in Merger Sub 2 represented by common units, of which 100 units are issued and outstanding on the date hereof and owned by New PubCo;
WHEREAS, pursuant to that certain Agreement and Plan of Merger by and among Old PubCo, New PubCo and Amneal Merger Sub1 Inc., dated as of November 7, 2023 (the “Old PubCo Merger Agreement”), Amneal Merger Sub 1 Inc., a Delaware corporation and a direct, wholly owned subsidiary of New PubCo, merged with and into Old PubCo, with Old PubCo surviving the Merger (the “Old PubCo Merger”);
WHEREAS, in connection with the Old PubCo Merger, (i) each share of Class A common stock, par value $0.01 per share, of Old PubCo (“Old PubCo Class A Common Stock”) issued and outstanding immediately prior to the Old PubCo Merger was converted into one validly issued, fully paid and nonassessable share of Class A common stock, par value $0.01 per share, of New PubCo (“New PubCo Class A Common Stock”) and (ii) each share of Class B common stock, par value $0.01 per share, of Old PubCo issued and outstanding immediately prior to the Old PubCo Merger was converted into one validly issued, fully paid and nonassessable share of Class B common stock, par value $0.01 per share, of New PubCo (“New PubCo Class B Common Stock”);